| |
|
| |
 |
| |
|
| |
|
Technology Platform |
| |
|
Our proprietary platform uses next generation genomic, epigenomic, and other molecular technologies to optimize biomarker and target accuracy |
| |
|
Find out More |
|
| |
|
| |
 |
| |
|
| |
|
Scientific Presentations and Publications |
| |
|
Peer reviewed scientific data help guide our diagnostic and therapeutic development decisions |
| |
|
Find out More |
|
|
| Recent News |
|
5.20.13
Ignyta Announces Acquisition of Actagene Oncology and E... |
read more
|
5.06.13
Ignyta and UC San Diego Researchers Find that Permanent... |
read more
|
3.20.13
Ignyta Appoints Dr. Tom Huizinga to Scientific Advisory... |
read more
|
 |
|
|
